Proof that this was a "cleaner" Tour



M

Mark VandenBerghe

Guest
WSJ NEWS ALERT: Amgen Plans to Cut Work Force Amid Slump in Aranesp Drug

from The Wall Street Journa

Aug. 15, 2007

Amgen said it will cut staff by up to 14%, slash capital expenses by $1.9
billion, and close some production facilities in an effort to offset
slumping sales of its top-selling anemia drug Aranesp. The restructuring --
unprecedented in the biotech giant's 27-year history -- will trigger $600
million to $700 million in pre-tax charges. Amgen also cut its 2007 earnings
estimate, previously $4.28 a share, down to a range of $4.13 to $4.23,
compared with $3.90 a year earlier.

FOR MORE INFORMATION, see:
http://wsj.com/article/0,,SB118720529438898746,00.html?mod=djemalert
 
"Dan Connelly" <d_j_c_o_n_n_e_l@y_a_h_o_o_._c_o_m> wrote in message
news:[email protected]...
> Mark VandenBerghe wrote:
>> WSJ NEWS ALERT: Amgen Plans to Cut Work Force Amid Slump in Aranesp Drug
>>

>
> They should advertise in:
> http://www.geezerjock.com/public/335.cfm


Dsn, you're beginning to have some serious problems. I suggest you aren't
winning because you're getting older.